The global Nano-based Drug Delivery System market size is predicted to grow from US$ 4781 million in 2025 to US$ 5575 million in 2031; it is expected to grow at a CAGR of 2.6% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淣ano-based Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Nano-based Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Nano-based Drug Delivery System sales for 2025 through 2031. With Nano-based Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nano-based Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Nano-based Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nano-based Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nano-based Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nano-based Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nano-based Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Nano-based Drug Delivery System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Less than 50nm
50-150nm
150-300nm
Others
Segmentation by Application:
Hydrophilic Drugs
Hydrophobic Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nano-based Drug Delivery System Market Size (2020-2031)
2.1.2 Nano-based Drug Delivery System Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nano-based Drug Delivery System by Country/Region (2020, 2024 & 2031)
2.2 Nano-based Drug Delivery System Segment by Type
2.2.1 Less than 50nm
2.2.2 50-150nm
2.2.3 150-300nm
2.2.4 Others
2.3 Nano-based Drug Delivery System Market Size by Type
2.3.1 Nano-based Drug Delivery System Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nano-based Drug Delivery System Market Size Market Share by Type (2020-2025)
2.4 Nano-based Drug Delivery System Segment by Application
2.4.1 Hydrophilic Drugs
2.4.2 Hydrophobic Drugs
2.5 Nano-based Drug Delivery System Market Size by Application
2.5.1 Nano-based Drug Delivery System Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nano-based Drug Delivery System Market Size Market Share by Application (2020-2025)
3 Nano-based Drug Delivery System Market Size by Player
3.1 Nano-based Drug Delivery System Market Size Market Share by Player
3.1.1 Global Nano-based Drug Delivery System Revenue by Player (2020-2025)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Player (2020-2025)
3.2 Global Nano-based Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nano-based Drug Delivery System by Region
4.1 Nano-based Drug Delivery System Market Size by Region (2020-2025)
4.2 Global Nano-based Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nano-based Drug Delivery System Market Size Growth (2020-2025)
4.4 APAC Nano-based Drug Delivery System Market Size Growth (2020-2025)
4.5 Europe Nano-based Drug Delivery System Market Size Growth (2020-2025)
4.6 Middle East & Africa Nano-based Drug Delivery System Market Size Growth (2020-2025)
5 Americas
5.1 Americas Nano-based Drug Delivery System Market Size by Country (2020-2025)
5.2 Americas Nano-based Drug Delivery System Market Size by Type (2020-2025)
5.3 Americas Nano-based Drug Delivery System Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nano-based Drug Delivery System Market Size by Region (2020-2025)
6.2 APAC Nano-based Drug Delivery System Market Size by Type (2020-2025)
6.3 APAC Nano-based Drug Delivery System Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size by Country (2020-2025)
7.2 Europe Nano-based Drug Delivery System Market Size by Type (2020-2025)
7.3 Europe Nano-based Drug Delivery System Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nano-based Drug Delivery System by Region (2020-2025)
8.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2020-2025)
8.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nano-based Drug Delivery System Market Forecast
10.1 Global Nano-based Drug Delivery System Forecast by Region (2026-2031)
10.1.1 Global Nano-based Drug Delivery System Forecast by Region (2026-2031)
10.1.2 Americas Nano-based Drug Delivery System Forecast
10.1.3 APAC Nano-based Drug Delivery System Forecast
10.1.4 Europe Nano-based Drug Delivery System Forecast
10.1.5 Middle East & Africa Nano-based Drug Delivery System Forecast
10.2 Americas Nano-based Drug Delivery System Forecast by Country (2026-2031)
10.2.1 United States Market Nano-based Drug Delivery System Forecast
10.2.2 Canada Market Nano-based Drug Delivery System Forecast
10.2.3 Mexico Market Nano-based Drug Delivery System Forecast
10.2.4 Brazil Market Nano-based Drug Delivery System Forecast
10.3 APAC Nano-based Drug Delivery System Forecast by Region (2026-2031)
10.3.1 China Nano-based Drug Delivery System Market Forecast
10.3.2 Japan Market Nano-based Drug Delivery System Forecast
10.3.3 Korea Market Nano-based Drug Delivery System Forecast
10.3.4 Southeast Asia Market Nano-based Drug Delivery System Forecast
10.3.5 India Market Nano-based Drug Delivery System Forecast
10.3.6 Australia Market Nano-based Drug Delivery System Forecast
10.4 Europe Nano-based Drug Delivery System Forecast by Country (2026-2031)
10.4.1 Germany Market Nano-based Drug Delivery System Forecast
10.4.2 France Market Nano-based Drug Delivery System Forecast
10.4.3 UK Market Nano-based Drug Delivery System Forecast
10.4.4 Italy Market Nano-based Drug Delivery System Forecast
10.4.5 Russia Market Nano-based Drug Delivery System Forecast
10.5 Middle East & Africa Nano-based Drug Delivery System Forecast by Region (2026-2031)
10.5.1 Egypt Market Nano-based Drug Delivery System Forecast
10.5.2 South Africa Market Nano-based Drug Delivery System Forecast
10.5.3 Israel Market Nano-based Drug Delivery System Forecast
10.5.4 Turkey Market Nano-based Drug Delivery System Forecast
10.6 Global Nano-based Drug Delivery System Forecast by Type (2026-2031)
10.7 Global Nano-based Drug Delivery System Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nano-based Drug Delivery System Forecast
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Nano-based Drug Delivery System Product Offered
11.1.3 Amgen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Nano-based Drug Delivery System Product Offered
11.2.3 Teva Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Nano-based Drug Delivery System Product Offered
11.3.3 Roche Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Information
11.4.2 UCB (Union Chimique Belge) Nano-based Drug Delivery System Product Offered
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 UCB (Union Chimique Belge) Main Business Overview
11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Nano-based Drug Delivery System Product Offered
11.5.3 Celgene Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Nano-based Drug Delivery System Product Offered
11.6.3 Merck Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Information
11.7.2 Gilead Sciences Nano-based Drug Delivery System Product Offered
11.7.3 Gilead Sciences Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gilead Sciences Main Business Overview
11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Nano-based Drug Delivery System Product Offered
11.8.3 Sanofi Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nano-based Drug Delivery System Product Offered
11.9.3 Pfizer Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Nano-based Drug Delivery System Product Offered
11.10.3 Takeda Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Information
11.11.2 Bausch&Lomb Nano-based Drug Delivery System Product Offered
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bausch&Lomb Main Business Overview
11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Information
11.12.2 Samyang Biopharmaceuticals Nano-based Drug Delivery System Product Offered
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Samyang Biopharmaceuticals Main Business Overview
11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Nano-based Drug Delivery System Product Offered
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Information
11.14.2 TOLMAR Nano-based Drug Delivery System Product Offered
11.14.3 TOLMAR Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 TOLMAR Main Business Overview
11.14.5 TOLMAR Latest Developments
11.15 Astellas
11.15.1 Astellas Company Information
11.15.2 Astellas Nano-based Drug Delivery System Product Offered
11.15.3 Astellas Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Astellas Main Business Overview
11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Information
11.16.2 AMAG Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 AMAG Pharmaceuticals Main Business Overview
11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
11.17.1 AbbVie Company Information
11.17.2 AbbVie Nano-based Drug Delivery System Product Offered
11.17.3 AbbVie Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 AbbVie Main Business Overview
11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Information
11.18.2 Dr Reddy Nano-based Drug Delivery System Product Offered
11.18.3 Dr Reddy Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Dr Reddy Main Business Overview
11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Information
11.19.2 AstraZeneca Nano-based Drug Delivery System Product Offered
11.19.3 AstraZeneca Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 AstraZeneca Main Business Overview
11.19.5 AstraZeneca Latest Developments
11.20 Aspen
11.20.1 Aspen Company Information
11.20.2 Aspen Nano-based Drug Delivery System Product Offered
11.20.3 Aspen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Aspen Main Business Overview
11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Information
11.21.2 Acrotech Biopharma Nano-based Drug Delivery System Product Offered
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Acrotech Biopharma Main Business Overview
11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Information
11.22.2 TWi Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 TWi Pharmaceuticals Main Business Overview
11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
